Ashley Ivor Simon Morris
Keine laufenden Positionen mehr
Profil
Ashley Ivor Simon Morris served as the Area Director at PT Organon Pharma Indonesia Tbk from 2004 to 2009.
In 2017, he briefly served as the Chief Executive Officer & Executive Director at SciGen Pte Ltd.
Morris obtained his undergraduate degree from The University of Nottingham in 2013.
Ehemalige bekannte Positionen von Ashley Ivor Simon Morris
Unternehmen | Position | Ende |
---|---|---|
SCIGEN LIMITED | Vorstandsvorsitzender | 08.09.2017 |
MERCK SHARP DOHME PHARMA TBK PT | Corporate Officer/Principal | 01.01.2009 |
Ausbildung von Ashley Ivor Simon Morris
The University of Nottingham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERCK SHARP DOHME PHARMA TBK PT | Health Technology |
Private Unternehmen | 1 |
---|---|
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |